In fact, IGF-1R, the upstream receptor of IRS-1, has been suggested to be a potential therapeutic target in GIST [36], in addition to being a diagnostic marker for non-intestinal GIST [14]. The gene discussed is IGF1R; the disease is gastrointestinal stromal tumor.